Credit Agricole
AYTU icon

Credit Agricole’s AYTU BioPharma AYTU Stock Holding History

Credit Agricole’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$6 Hold
5
– – ﹤0.01% 1263
2024
Q4 		$9 Buy
+5
New +$9 ﹤0.01% 1274

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Credit Agricole's AYTU Position: Q1 2025 in Review

Credit Agricole held its AYTU BioPharma (AYTU) position steady in Q1 2025 at 5 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #1263.

Credit Agricole first reported a position in AYTU in Q4 2024 and has held it in 2 quarters since. The position peaked at $9 in Q4 2024. 31 funds tracked by Wall St. Rank hold AYTU as of Q1 2025.

  • Credit Agricole held 5 shares of AYTU BioPharma worth $6 as of Q1 2025.
  • Credit Agricole left its AYTU BioPharma share count unchanged in Q1 2025.
  • AYTU BioPharma made up ﹤0.01% of Credit Agricole's portfolio in Q1 2025, its #1263 holding.
  • Credit Agricole first reported a position in AYTU BioPharma in Q4 2024 and has held it in 2 quarters since.
  • Credit Agricole's AYTU BioPharma position peaked at $9 in Q4 2024.
  • 31 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.